Literature DB >> 27530138

Transarterial venous sinus occlusion of dural arteriovenous fistulas using ONYX.

Collin M Torok1, Raul G Nogueira2, Albert J Yoo3, Thabele M Leslie-Mazwi1, Joshua A Hirsch1, Christopher J Stapleton1, Aman B Patel1, James D Rabinov4.   

Abstract

PURPOSE: The purpose of this article is to present a case series of transarterial venous sinus occlusion for dural arteriovenous fistulas (DAVFs) of the transverse and sigmoid sinuses.
MATERIALS AND METHODS: From 2006 to 2012, 11 patients with DAVF of the transverse and sigmoid sinuses were treated with transarterial closure of the affected venous sinus using ethylene vinyl alcohol copolymer (ONYX). The consecutive retrospective cohort included six female and five male patients with an age range of 30-79. Patients presented with stroke, intracranial hemorrhage, seizure, headache, focal neurologic deficit or cognitive change. Lesions were categorized as Cognard II a + b (n = 5) or Cognard II b (n = 6). Four of this latter group consisted of isolated sinus segments. Selection criteria for dural sinus occlusion included direct multi-hole fistulas involving a broad surface in length or circumference of the sinus wall. External carotid artery (ECA) branches were directly embolized when considered safe. High-risk arterial supply from ICA, PICA, AICA or ECA cranial nerve branches were closed via retrograde approach during sinus occlusion.
RESULTS: DAVF closure was accomplished in all 11 patients with a total of 17 embolization procedures using ONYX. High-risk arterial collaterals were closed via artery-artery or artery-sinus-artery embolization. The vein of Labbe was spared in the four cases with initial antegrade flow. No neurologic complications occurred, and DAVF closures were durable on three-month angiography.
CONCLUSION: Transarterial closure of the transverse and sigmoid sinuses.
© The Author(s) 2016.

Entities:  

Keywords:  Dural arteriovenous fistula; ONYX; embolization

Mesh:

Substances:

Year:  2016        PMID: 27530138      PMCID: PMC5564366          DOI: 10.1177/1591019916663478

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  21 in total

1.  Transvenous treatment of spontaneous dural carotid-cavernous fistulas using a combination of detachable coils and Onyx.

Authors:  S Suzuki; D W Lee; R Jahan; G R Duckwiler; F Viñuela
Journal:  AJNR Am J Neuroradiol       Date:  2006 Jun-Jul       Impact factor: 3.825

2.  ONYX versus n-BCA for embolization of cranial dural arteriovenous fistulas.

Authors:  James David Rabinov; Albert J Yoo; Christopher S Ogilvy; Bob S Carter; Joshua A Hirsch
Journal:  J Neurointerv Surg       Date:  2012-05-01       Impact factor: 5.836

3.  Therapeutic management of intracranial dural arteriovenous shunts with leptomeningeal venous drainage: report of 53 consecutive patients with emphasis on transarterial embolization with acrylic glue.

Authors:  Pierre Guedin; Stephan Gaillard; Anne Boulin; Stephanie Condette-Auliac; Frederic Bourdain; Stephanie Guieu; Michel Dupuy; Georges Rodesch
Journal:  J Neurosurg       Date:  2010-03       Impact factor: 5.115

Review 4.  Early rebleeding from intracranial dural arteriovenous fistulas: report of 20 cases and review of the literature.

Authors:  H Duffau; M Lopes; V Janosevic; J P Sichez; T Faillot; L Capelle; M Ismaïl; A Bitar; F Arthuis; D Fohanno
Journal:  J Neurosurg       Date:  1999-01       Impact factor: 5.115

5.  Endovascular treatment of intracranial dural arteriovenous fistulas with cortical venous drainage: new management using Onyx.

Authors:  C Cognard; A C Januel; N A Silva; P Tall
Journal:  AJNR Am J Neuroradiol       Date:  2007-11-07       Impact factor: 3.825

6.  Natural history of dural arteriovenous shunts.

Authors:  Michael Söderman; Ladislav Pavic; Göran Edner; Staffan Holmin; Tommy Andersson
Journal:  Stroke       Date:  2008-04-03       Impact factor: 7.914

7.  Nonadhesive liquid embolic agent for cerebral arteriovenous malformations: preliminary histopathological studies in swine rete mirabile.

Authors:  Y Murayama; F Viñuela; A Ulhoa; Y Akiba; G R Duckwiler; Y P Gobin; H V Vinters; R J Greff
Journal:  Neurosurgery       Date:  1998-11       Impact factor: 4.654

8.  Complex dural arteriovenous fistulas. Results of combined endovascular and neurosurgical treatment in 16 patients.

Authors:  S L Barnwell; V V Halbach; R T Higashida; G Hieshima; C B Wilson
Journal:  J Neurosurg       Date:  1989-09       Impact factor: 5.115

9.  Use of a wedged microcatheter for curative transarterial embolization of complex intracranial dural arteriovenous fistulas: indications, endovascular technique, and outcome in 21 patients.

Authors:  Peter Kim Nelson; Stephen M Russell; Henry H Woo; Anthony J G Alastra; Danko V Vidovich
Journal:  J Neurosurg       Date:  2003-03       Impact factor: 5.115

10.  Cerebral dural arteriovenous fistulas: clinical and angiographic correlation with a revised classification of venous drainage.

Authors:  C Cognard; Y P Gobin; L Pierot; A L Bailly; E Houdart; A Casasco; J Chiras; J J Merland
Journal:  Radiology       Date:  1995-03       Impact factor: 11.105

View more
  3 in total

1.  Single-session hematoma removal and transcortical venous approach for coil embolization of an isolated transverse-sigmoid sinus dural arteriovenous fistula in a hybrid operating room: illustrative case.

Authors:  Izumi Yamaguchi; Yasuhisa Kanematsu; Kenji Shimada; Nobuaki Yamamoto; Kazuhisa Miyake; Takeshi Miyamoto; Shu Sogabe; Eiji Shikata; Manabu Ishihara; Yuki Yamamoto; Kazutaka Kuroda; Yasushi Takagi
Journal:  J Neurosurg Case Lessons       Date:  2022-05-23

2.  Feasibility and Effectiveness of Direct Puncture and Onyx Embolization for Transverse Sinus Dural Arteriovenous Fistula.

Authors:  Taek Kyun Nam; Jun Soo Byun; Hyun Ho Choi; Mi Sun Chung; Eun Jung Lee
Journal:  Yonsei Med J       Date:  2019-11       Impact factor: 2.759

3.  Progress in research on intracranial multiple dural arteriovenous fistulas.

Authors:  Yunbao Guo; Jing Yu; Ying Zhao; Jinlu Yu
Journal:  Biomed Rep       Date:  2017-11-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.